Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00694512 · ClinicalTrials.gov registry record · NA

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

A NA study of Obesity, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
51
Enrollment target
1
Study location

NCT00694512 is a NA study of Obesity that has completed, run by Oregon Health and Science University. The registered enrollment target is 51 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00694512, a NA study of Obesity, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Low fat diet
  • DIETARY_SUPPLEMENT High fat diet
  • DIETARY_SUPPLEMENT MCT diet

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2008-02
Est. Completion 2011-03
Phase NA

What the Registry Record Tells You About NCT00694512

The ClinicalTrials.gov registry entry for NCT00694512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Low fat diet is the first listed.

NCT00694512 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00694512 about?

NCT00694512 is a clinical study titled "Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin". The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

What is the current status of trial NCT00694512?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2008-02. Estimated completion is 2011-03.

What conditions does trial NCT00694512 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00694512?

The interventions under investigation include: Low fat diet (DIETARY_SUPPLEMENT), High fat diet (DIETARY_SUPPLEMENT), MCT diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00694512?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00694512 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.